STC2 and nasopharyngeal carcinoma: Our results showed that STC2 targets SOX6 by activating ITGB2/FAK, thereby regulating the transcription of the downstream of SOX6, which has significant impacts on cell proliferation, EMT, and glycolysis in NPC.